血清肌酐二步酶法检测新技术研究

检验医学 ›› 2012, Vol. 27 ›› Issue (10): 809-812.

血清肌酐二步酶法检测新技术研究

梁夯¹,冯志军¹,李立和²,张学英¹,李晓燕¹

1. 天津市大港油田总医院检验科，天津 300280；2. 天津市宝坻区人民医院检验科，天津 301800

收稿日期:2012-07-09 修回日期:2012-07-24 出版日期:2012-10-30 发布日期:2012-10-12
作者简介:梁夯，男，1970年生，副主任技师，主要从事生物化学检验项目的诊断性研究。

Investigation on the new two-step enzymatic method for the detection of serum creatinine

1. Department of Clinical Laboratory，Oilfield Hospital of Tianjin Dagang，Tianjin 300280，China； 2. Department of Clinical Laboratory，the People′s Hospital of Tianjin Baodi，Tianjin 301800，China

Received:2012-07-09 Revised:2012-07-24 Online:2012-10-30 Published:2012-10-12

摘要/Abstract

摘要： 目的　探讨二步酶法测定肌酐的实验方法。方法　以肌酐酰氨基水解酶为试剂Ⅱ，以N-(2-羟基-3-磺丙基)-3，5-二甲氧基苯胺钠盐（HDAOS）和4-氨基安替比林（4-AAP）色原物作为试剂Ⅰ，建立二步酶法测定血清肌酐。通过内空白法消除内源性肌酸和改变光谱吸收方法消除脂血、溶血、黄疸干扰。采用二步酶法测定36例患者血清肌酐，并与高效液相色谱（HPLC）法和一步酶法比较；同时测定200名健康体检者血清肌酐，以建立参考范围。结果　患者组肌酐二步酶法结果[(84.2±26.6) μmol/L]明显低于一步酶法[(116.6±29.6) μmol/L，t＝32.12，P＜0.01]；与HPLC法测定结果[(83.9±26.8)μmol/L]差异无统计学意义（t＝0.541 6，P＞0.05），且呈良好相关性（Y_二步酶法＝1.042X_HPLC_法－0.182 1，r²＝0.982 4）。二步酶法测定血清肌酐的线性范围达4 500 μmol/L，平均回收率为100.8％，批内和批间变异系数(CV)分别为2.91%～4.20%和3.20%～4.60%，应用二步酶法每天测定室内质控定值血清[低（78.0 μmol/L）、中（206.0 μmol/L）、高（900.0 μmol/L）]，共测定180 d，其日间总CV分别为4.46%、5.27%、7.24%。二步酶法试剂至少能稳定180 d。健康人群血清肌酐的参考范围男性为56～132 μmol/L，女性为41～109 μmol/L。结论　以肌酐酰氨基水解酶为试剂Ⅱ和以HDAOS、4-AAP为色原物（试剂Ⅰ）的二步酶法可以消除肌酸和脂血、溶血、黄疸血的干扰，可用于临床肌酐常规测定。

关键词: 肌酐, 二步酶法, 内空白法, N-(2-羟基-3-磺丙基)-3, 5-二甲氧基苯胺钠盐, 内源性干扰

Abstract: Objective　To investigate the two-step enzymatic method for the detection of serum creatinine. Methods　　The two-step enzymatic method for the detection of serum creatinine was established using creatinine amidohydrolase as the reagent Ⅱ and N-(2-hydroxy-3-sulfopropyl)-3，5-dimethoxyaniline sodium salt（HDAOS）and 4-mino-antipyrine (4-AAP) as the reagent Ⅰ. The inner blank method was used to eliminate endogenous creatine, and altered spectral absorption method was used to eliminate the interference of lipemia, hemolysis and jaundice. The levels of serum creatinine in 36 patients were determined by the two-step enzymatic method. The results were compared with those of high performance liquid chromatography (HPLC) and single-reagent method. The serum creatinine levels of 200 healthy subjects were determined and performed as reference range. Results　There was significant difference between two-step enzymatic method[creatinine：（84.2±26.6）μmol/L] and single-reagent method [creatinine：(116.6±29.6)μmol/L, t=32.12，P＜0.01]，whereas there was no statistical significance between two-step enzymatic method and HPLC [creatinine：（83.9±26.8）μmol/L, t=0.541 6，P＞0.05], and showed good correlation (Y_{two-step enzymatic method} =1.042X_HPLC－0.182 1，r²＝0.982 4). The liner range of the two-step enzymatic method for the detection of serum creatinine was up to 4 500 μmol/L,the average rate of recovery was 100.8％，and the within-run coefficient of variation (CV) and between-run CV were 2.91%-4.20% and 3.20%-4.60%. The sera [low level：78.0 μmol/L, middle level：206.0 μmol/L and high level：900.0 μmol/L] were determined by the two-step enzymatic method for 180 d. The interday CV were 4.46%, 5.27% and 7.24%. The reagents of the two-step enzymatic method could be stable at least for 180 d. The reference range of serum creatinine in healthy males was 56-132 μmol/L, and that in healthy females was 41-109 μmol/L. Conclusions　The two-step enzymatic method based on creatinine amidohydrolase as reagent Ⅱ and based on HDAOS and 4-AAP as reagent Ⅰ could eliminate the interference of creatine，lipemia，hemolysis and jaundice, and it can be applied as routine test.

Key words: Creatinine, Two-step enzymatic method, Inner blank method, N-（2-hydrroxt-3-sulfopropyl）-3, 5-dimethoxyaniline sodium salt, Endogenous interference

梁夯1，冯志军1，李立和2，张学英1，李晓燕1. 血清肌酐二步酶法检测新技术研究[J]. 检验医学, 2012, 27(10): 809-812.

LIANG Hang 1 ，FENG Zhijun 1，LI Lihe 2，ZHANG Xueying 1, LI Xiaoyan 1. Investigation on the new two-step enzymatic method for the detection of serum creatinine[J]. , 2012, 27(10): 809-812.

[1]	李莲, 黄晓玲, 姚娟. 高浓度肌酸致血清肌酐酶法检测结果假性升高病例分析[J]. 检验医学, 2023, 38(5): 497-501.
[2]	顾刚, 欧维正, 陶铜芳, 董江义. 改良肌氨酸氧化酶法肌酐试剂抗高IgM干扰分析[J]. 检验医学, 2023, 38(3): 294-296.
[3]	张水检, 周琰, 邵文琦, 张春燕, 潘柏申, 王蓓丽, 郭玮. 半定量干化学法检测尿白蛋白/肌酐比值的临床应用价值[J]. 检验医学, 2022, 37(5): 463-465.
[4]	贾珂珂, 孙文苑, 聂睿, 崔丽艳. 免疫透射比浊法常见干扰因素的识别与应对策略[J]. 检验医学, 2021, 36(4): 362-368.
[5]	邵文琦, 于正麟, 吴群, 张春燕, 王蓓丽, 潘柏申, 郭玮. 盐酸利多卡因致血清干化学肌酐定量结果异常1例报道[J]. 检验医学, 2021, 36(4): 381-383.
[6]	张卫威, 景蓉蓉, 季伙燕, 王建新, 王峰, 王惠民. 同位素稀释质谱法测定血清肌酐浓度的不确定度评定[J]. 检验医学, 2021, 36(3): 263-269.
[7]	徐文俊, 李甲勇, 李会丹. 不同eGFR公式与ACR联合应用在肾功能损伤高危人群中的临床价值[J]. 检验医学, 2021, 36(1): 13-19.
[8]	张科, 童书韬, 张德太. 初发甲状腺功能异常患者血清甲状腺激素与Cr、Cys C的相关性[J]. 检验医学, 2020, 35(7): 691-694.
[9]	金中淦, 居漪, 李卿, 唐立萍, 虞啸炫, 刘文彬, 欧元祝. 2016年上海地区肌酐、尿酸、尿素正确度验证结果分析[J]. 检验医学, 2018, 33(4): 348-352.
[10]	王正印, 尹元, 王伟灵. 肌酐检测方法及常见药物对肌酐检测干扰的研究进展[J]. 检验医学, 2018, 33(4): 370-373.
[11]	张如霖, 王弘明, 彭霞, 李甲勇, 李莉. 血清淀粉样蛋白A、胱抑素C与尿白蛋白/肌酐比值联合检测在早期糖尿病肾病中的诊断价值[J]. 检验医学, 2018, 33(2): 97-100.
[12]	杨术生, 李琼, 王伟, 范军秀, 方欢英. 间接法建立血清肌酐参考区间[J]. 检验医学, 2018, 33(10): 879-883.
[13]	陈时维, 叶志成, 付盼, 李巍, 杨丹, 徐锦. 上海地区儿童肾功能生化项目参考区间的建立[J]. 检验医学, 2018, 33(10): 884-887.
[14]	许丽媛, 应春妹. 妊娠中、晚期妇女肾功能指标的检测及其参考区间的建立[J]. 检验医学, 2017, 32(8): 682-685.
[15]	张国明, 张高明, 马小波, 王登海. 健康体检人群肌酐同步检测尿素非必要性分析[J]. 检验医学, 2017, 32(12): 1118-1120.